This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Dr. Elias Post, PhD
Senior Scientist at Synaffix/Lonza
Speaker

Profile

Elias Post obtained his DPhil in organic chemistry in the group of Prof. Dr. Stephen Fletcher from the University of Oxford in 2020. He started his career at Evotec working on the synthesis of PROTACs and the development of novel ligands targeting E3 ligases. Subsequently, he joined Synaffix where he has managed a team working on several R&D projects. One such project has enabled the conjugation of oligonucleotides to antibodies via the GlycoConnectTM technology platform to form AOCs with unprecedented in vivo efficacy.

Agenda Sessions

  • GlycoConnect Antibody-oligonucleotide Conjugates for Targeted Treatment of Neuromuscular Diseases

    15:00